MARSHALL WACE, LLP

Position in SIBN — SI-BONE, Inc.

CIK 1318757 LONDON, X0

Position in SIBN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,123,456

-$4,500,037 QoQ

Shares Held

168,128

-49.9% QoQ

Ownership

0.379%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. SIBN ranks #32 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	3,611,020	$226,591,504
2	SYK	Stryker Corp	630,236	$207,089,246
3	ABT	Abbott Laboratories	2,010,938	$206,463,003
4	EW	Edwards Lifesciences Corp	1,996,377	$159,869,868
5	PODD	Insulet Corp	606,482	$127,264,182
6	GMED	Globus Medical Inc	562,630	$48,476,200
7	TNDM	Tandem Diabetes Care Inc	1,442,472	$27,652,186
8	HAE	Haemonetics Corp	320,010	$18,035,762

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,123,456	168,128	-49.9%	Shares	Other	2026-05-15
2025-12-31	$6,623,493	335,877	+74.7%	Shares	Other	2026-02-13
2025-09-30	$2,830,361	192,280	-55.9%	Shares	Other	2025-11-13
2025-06-30	$8,209,527	436,213	+18.2%	Shares	Other	2025-08-13
2025-03-31	$5,177,223	369,011	+39.5%	Shares	Other	2025-05-15
2024-12-31	$3,708,610	264,523	+332.5%	Shares	Other	2025-02-13
2024-09-30	$855,044	61,162	-70.7%	Shares	Other	2024-11-14
2024-06-30	$2,698,309	208,686	+49.9%	Shares	Other	2024-08-14
2024-03-31	$2,279,702	139,261	-56.5%	Shares	Other	2024-05-15
2023-12-31	$6,727,420	320,506	-28.9%	Shares	Other	2024-02-14
2023-09-30	$9,569,448	450,539	-20.3%	Shares	Other	2023-11-14
2023-06-30	$15,254,195	565,389	+7842.0%	Shares	Other	2023-08-14
2021-03-31	$226,455	7,119	-81.2%	Shares	Sole	2021-05-17
2020-12-31	$1,132,372	37,872	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.